Skip to main content

A retrospective review of the community medicine needs from osteoporosis services in Canada

Abstract

Background

Comprehensive, real-world osteoporosis care has many facets not explicitly addressed in practice guidelines. We sought to determine the areas of knowledge and practice needs in osteoporosis medicine for the purpose of developing an osteoporosis curriculum for specialist trainees and knowledge translation tools for primary care.

Methods

This was a retrospective review of referral questions received from primary care and specialists to an academic, multi-disciplinary tertiary osteoporosis and metabolic bone clinic. There were 400 referrals in each of 5 years (2015–2019) selected randomly for review. The primary referral question was elucidated and assigned to one of 16 pre-determined referral topics reflecting questions in the care of osteoporosis and metabolic bone patients. The top 7 referral topics by frequency were determined while recording the referral source.

Results

The majority of referrals (71%) came from urban primary care. The most common specialists to request care included rheumatology, oncology, gastroenterology and orthopedic surgery (fracture liaison services). Primary care referrals predominantly requested assistance with routine osteoporosis assessments, bisphosphonate holidays, bisphosphonate adverse effects/alternatives, fractures occurring despite therapy and adverse changes on bone densitometry despite treatment. Specialists most often referred patients with complex secondary bone diseases or cancer. The main study limitation was that knowledge needs of referring physicians were inferred from the referral question rather than tested directly.

Conclusion

By assessing actual community demand for services, this study identified several such topics that may be useful targets to develop high quality knowledge translation tools and curriculum design in programs training specialists in osteoporosis care.

Peer Review reports

Introduction

Age-related osteoporosis and fragility fractures are the most common forms of metabolic bone problems in modern medicine [1], affecting 16 to 30% of people over the age of 50 with higher rates in those over 80 years old [2]. To assist primary care providers in clinical practice, many countries have regularly updated osteoporosis practice guidelines to optimize the detection, assessment and treatment of individuals at the highest risk of fracture [3,4,5,6]. However, the actual clinical practice of bone medicine is necessarily more complex than may be addressed in general osteoporosis guidelines. Therefore, while many aspects of osteoporosis care have been managed in the primary care setting, bone medicine specialists are called upon to address less-common metabolic bone disorders and to support clinical decisions within areas of controversy related to osteoporosis care.

It is important to understand the needs of a population in order to develop resources required to address the issues of patients in both primary and specialist care. Osteoporosis-related knowledge translation programs directed at primary care audiences may benefit from objective measures that can reliably guide topics for continuing professional development and areas for guideline writers to address. Additionally, residency training programs in internal medicine/geriatrics, endocrinology and rheumatology may benefit from an osteoporosis-specific curriculum that focusses on the measured needs of the community. In this way, both primary and specialist care providers may be prepared to work together for the majority of community needs.

To categorize and quantify the community osteoporosis needs, as defined by the real-world practice, we conducted a detailed, retrospective review of a large sample of referrals sent to a multi-disciplinary metabolic bone and osteoporosis clinic serving both urban and rural primary care as well as other medical sub-specialists. The primary aim was to determine the most common needs and knowledge care gaps in osteoporosis medicine, in order to inform future guideline writers and medical curriculum developers.

Methods

This study was approved by the ARECCI ethics board of Alberta Innovates; as a retrospective quality-focused study, waiver of individual patient consent was granted and study conduct followed the relevant guidelines and regulations. The Dr. David Hanley Osteoporosis Centre (DHOC) is a multi-disciplinary clinic in Calgary, Canada, devoted to the care of all forms of osteoporosis/metabolic bone disease in Southern Alberta and surrounding area, serving a population of at least 1.3 million people. The clinic is staffed by 5 physicians with expertise in bone medicine, along with a dedicated bone pharmacist, nurse-clinician, dietitian and clinical support staff. The DHOC offers a wide range of in-person and online education for patients and the general public, in addition to individual consultation services. The DHOC receives referrals directly from both primary care and specialist physicians as well as indirectly in transfer from the Central Access and Triage program of the Endocrinology and Rheumatology divisions (Calgary Zone), of Alberta Health Services.

In order to capture the consultative needs of the referring community, we conducted a manual review of referrals received at the DHOC between the years of 2015 to 2019. A sample size of 400 referrals per year was selected in order to capture the frequency of even rare referral questions. Original referrals to the DHOC are maintained in a secure central database categorized by year and in 6-month blocks (January-June, July-December). Individual referral files are kept in alphabetical order of last name within each block. In order to facilitate non-selective sampling, the first 400 alphabetical referrals from the first block of each year were selected for review. Each referral was reviewed in detail by a single reviewer (GK) with long-term experience in osteoporosis medicine and data manually abstracted for analysis. Basic demographic data was collected and after reading the referral text, the reviewer assigned the data to one of 16 pre-defined, possible categories depending on the primary referral question alone; the presence of additional factors that could possibly be congruent with another referral category were not considered unless they specifically factored in the primary question written by the referring physician. For example, “please see this 72 year old woman who just broke her wrist despite being on alendronate for 11 years,” contains data that could be relevant to a question of bisphosphonate holiday but the immediate, primary question being asked is around the issue of a patient sustaining a fracture despite treatment. A referral could be categorized into more than one referral type but only if the referral contained explicit wording of more than one question; simply inferring a second question was not permitted.

Referral question categories were derived from prior pilot data previously gathered during the routine clinical triage process and are outlined, with examples and narrative explanations, in Table 1. The original case categorization was developed informally as a means of assessing the various levels of acuity and complexity in the referrals being received, for the purpose of informing referral triage processes and clinical resource allocation. Data was analyzed using descriptive statistics as both a single dataset and according to annual blocks. ANOVA comparison of multiple continuously distributed non-parametric data was performed by the Kruskal–Wallis test and Dunn’s multiple comparisons test with multiply-adjusted p-value used for comparison of pairs within the ANOVA columns. Where comparison of proportions was performed, a chi-square test was used with the level of statistical significance set at p < 0.05. Statistical analysis was performed using GraphPad Prism 6.0 (LaJolla, California) and the project was approved by the ARECCI Quality Improvement program of Alberta Innovates; there was no external funding.

Table 1 Referral question categories with narrative examples

Results

During the 5-year sampling frame, there were an average of 1189 referrals received each year (total 5945). The typical patient demographic is displayed in Fig. 1 and Supplemental Table 1; there was no apparent change across 5 years. Approximately 87% of referred patients were women with a median age of 66 (range of 15 to 99) years. Note that 10% were patients under the age of 50 and most such referrals were for metabolic bone diseases (69.5%). Referrals from urban family practitioners comprised the majority (71%) with 13.7% from rural practitioners and 14.9% from other specialists. The most common referring specialists were gastroenterologists, oncologists, rheumatologists and the region-wide Fracture Liaison Service (FLS) that started in 2017 (Fig. 2), who refer on behalf of the orthopedic surgeons. Prior to the FLS program, orthopedic surgery accounted for 1.4% of referrals to the centre but by 2019, it was 5.0% (p = 0.0002).

Fig. 1
figure 1

Frequency distribution of patients by age referred to the Osteoporosis clinic, 2015–2019

Fig. 2
figure 2

Specialty of non-primary care based referrals to the Osteoporosis clinic, 2015–2019. Note that “orthopedic surgery” includes referrals from the Fracture Liaison Service which started in 2017. GI, gastroenterology, Onc, oncology, Rheum, rheumatology, Ortho, orthopedic surgery. “Other” includes all medical or surgical subspecialists not otherwise specifically listed

The distribution of common primary referral questions is shown in Fig. 3 with less common primary questions in Fig. 4. This demonstrates that there are 7 question categories that account for 89% of all consultation requests to specialist bone medicine: 1) metabolic bone diseases [a composite category] (16.7%), 2) bisphosphonate holiday (15.9%), 3) routine osteoporosis assessment (15.9%), 4) non-bisphosphonate medication options (12.5%), 5) adverse changes on DXA despite therapy (10.5%), 6) recent fracture without treatment (9.2%) and 7) fracture while on therapy (8.5%). From 2015 to 2019, there appeared to be a decrease in the proportion of referrals for bisphosphonate holiday (24% to 13%, p < 0.0001) and increase in the frequency of requests for routine osteoporosis assessments (13% to 20%, p < 0.0001). Figure 5 demonstrates that there are significant differences in the services requested by family practitioners compared to specialists. Referrals from the community practitioners were more likely to involve requests for routine osteoporosis assessments or issues around bisphosphonate use whereas specialists accounted for the majority of metabolic bone disease and cancer-treatment-related bone disease (p < 0.001 for all comparisons).

Fig. 3
figure 3

The nine most common primary referral questions, 2015–2019, by percentage of all referrals. See Table 1 for explanations and examples. #no Rx, fracture not on treatment, BP, bisphosphonate, OP, osteoporosis, DXA, dual x-ray absorptiometry, MBD, metabolic bone diseases, IV, intravenous

Fig. 4
figure 4

Less common primary referral questions, 2015–2019. See Table 1 for explanations and examples. CKD, chronic kidney disease, POI, premature ovarian insufficiency, AE, adverse event (atypical femur fracture, osteonecrosis of the jaw). Note that the 16th category, pain management only accounted for < 6 referrals and is not shown)

Fig. 5
figure 5

Most common referral questions according to whether the referral source was primary care or specialist. “*” indicates p < 0.05 by Chi-square test

Exploratory subgroup analysis of the age-distribution among different referral types showed that patients referred for “fracture on treatment” and “bisphosphonate holiday” were significantly older (median ages 73 [interquartile range 65–82] and 70 [64–77] respectively) than patients referred for “routine osteoporosis assessment” and “fracture without treatment” (median ages 63 [58–69] and 68 [60–77], adjusted p < 0.0001 for all comparisons).

Discussion

We have performed a large-scale, multi-year audit of our regional bone medicine specialty clinic (the only such clinic in Southern Alberta) and elucidated a number of key issues in osteoporosis medicine that generate consultation requests. The osteoporosis clinic provided service to both primary care and a wide range of specialists, including support to hospital-based FLS programs, although there were differences in the types of patients referred from each source. Although this area of medicine is often considered as “osteoporosis and senior’s health,” a meaningful proportion of consultation requests arise for patients under age 50 and those with non-osteoporosis metabolic bone disease.

A review of primary referral questions helps osteoporosis specialists better understand the needs of their referring community and may give insight as to the most common areas in routine osteoporosis care where family practitioners may feel as though more guidance is required. It is remarkable that 6 of the top 7 primary referral questions pertain to issues expected to arise in routine osteoporosis care, such as what to do with the patient who sustains a fracture despite taking an approved anti-fracture medication. Fracture despite therapy is common and reported in every single randomized controlled trial [7] of anti-fracture agents. Even the best available therapy, which reduces relative fracture risk by 50–70% [8, 9], will still see some patients fracture, especially those who are elderly and at high risk for fracture [10].

Our subgroup analysis looking at age distribution around certain referral questions showed that fracture on therapy and issues of bisphosphonate holiday were particularly seen in an older population; this is not surprising and points out that simply by virtue of increasing age and duration of therapy, fractures and questions of drug holiday will be expected in many patients. Unfortunately, although they increasingly acknowledge the need for long-term patient management plans, most guidelines do not give specific recommendations that can address the many clinical permutations around bisphosphonate holiday, fracture on therapy or sequential therapy [3, 4]. The science regarding interpretation and use of serial BMD is very unsettled [11,12,13,14] and even high profile guidelines offer frankly contradictory advice on this issue [5, 15]. This has led some writers to call for more comprehensively useful guideline recommendations, even if such recommendations cannot be fully supported by the highest level evidence [16]. Better still, this kind of real-world data may be useful to help identify research questions that are particularly relevant and desired by actual patients with osteoporosis. Until such evidence exists, primary care physicians my need to rely on specialty clinic support. Given our findings, one may hypothesize that lack of accessible bone health education and osteoporosis clinical support may be a contributor to both poor osteoporosis therapy uptake and adherence to therapy by patients [17, 18]. Addressing this problem will require either increasing access to osteoporosis specialty care or improving the confidence for broader osteoporosis management within primary care. In either case, this will necessitate key stakeholders and policy-makers to support the development and implementation of widespread knowledge translation and education initiatives within the osteoporosis field.

In addition, our systematic analysis provides the infrastructure for the development of a service-driven teaching curriculum for training programs in osteoporosis and other metabolic bone disorders. In order to serve the needs of the medical community, it is clear that training around osteoporosis guidelines is not sufficient. Our data shows that the bone specialist needs to be familiar with controversies in the field, the practical use of the entire osteoporosis therapeutic armamentarium, the proper radiologic and clinical interpretation of DXA-BMD, complex secondary osteoporosis assessments in addition to a very long list of uncommon bone diseases which actually comprise a significant cumulative portion of the clinical needs.

Previous approaches to creation of a musculo-skeletal teaching curriculum have involved surveying practicing members within a specialty (e.g. orthopedic surgery) in order to determine what is deemed important for their own residents [19, 20] however, this only incorporates the specialists’ view and does not consider the actual needs of the referral community. Community-based studies involving mailed questionnaires [21, 22] structured interviews [23] and educational packages [24] have attempted to measure the osteoporosis “knowledge needs” in patients, primary care and specialists. However, all of these study designs are subject to recall bias or the fact that many providers may not know what they do not know. Our approach to defining knowledge needs according to an actual review of real-patient referral questions is a novel approach to comprehensively defining the breadth and frequency of osteoporosis medicine topics in real-world practice. As osteoporosis potentially affects 77% of people over the age of 80 [2], the need for osteoporosis care is similar to what is required for other diseases of ageing such as cardiovascular disease or cancer therapies [25].

The greatest strength of our study is the large size; 2000 referrals reviewed gives sufficient ability to derive reasonable prevalence estimates of even uncommon referral questions- this is particularly useful to contextualize our study as an exercise in osteoporosis curriculum design. There are also some limitations to be considered; it is possible that five years may be too short an interval to observe long-term trends in referral questions arising in parallel with new directions in the osteoporosis field. Anecdotally, bisphosphonate holiday questions were hardly seen fifteen years ago. The referrals in this study were interpreted by a single experienced reviewer which aids with consistency of approach but could also introduce systematic interpretation bias. Nonetheless, even multiple reviewers could have mis-categorized referrals when the data or narrative is unclear or sparse in detail and referral quality was not defined or used as an inclusion criteria in order to avoid bias in selection for review. Some referrals could theoretically qualify in 2 or 3 question categories once assessed in person and it is impossible to know if the referral source intended or was aware of this; it is possible that the referral was sent due to multi-aspect complexity even if not explicitly stated. However, if anything, this emphasizes the reality of patient care in osteoporosis – patients’ problems might not be amenable to uni-dimensional categorization and osteoporosis guidelines and training will need to reflect a more complex integration of osteoporosis medicine principles in order to be truly useful for real-world patient care.

Summary

We conducted a large review of patient referrals sent to a full-service metabolic bone clinic over 5 years and found there are 7 common sub-groups of primary referral questions pertaining to osteoporosis care but also complex metabolic bone diseases. This real-world data provides important information to inform guideline writers, knowledge translation groups and specialty curriculum designers in osteoporosis care. Community-oriented training in osteoporosis is recommended in order to provide optimal support for the care of medical bone disorders in Canada. Primary care providers shoulder the majority of osteoporosis care in Canada and should be offered attractive and clinically useful tools to guide their decision-making across the entire span of osteoporosis care from screening to therapy end.

Availability of data and materials

Not publicly applicable to the present manuscript as it is contained within unique patient referral letters sent to a clinical osteoporosis centre. All data generated or analysed during this study are included in this published article.

References

  1. Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17:1726–33.

    CAS  Article  Google Scholar 

  2. Wright NC, Saag KG, Dawson-Hughes B, Khosla S, Siris ES. The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USA. Osteoporos Int. 2017;28(4):1225–32.

    CAS  Article  Google Scholar 

  3. Camacho PM, Petak SM, Binkley N, Clarke BL, Harris ST, Hurley DL, et al. American association of clinical endocrinologists and American college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis - 2016. Endocr Pract. 2016;23(22):1–42.

    Article  Google Scholar 

  4. Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D. Pharmacological management of osteoporosis in postmenopausal women: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2019;104:1595–622.

    Article  Google Scholar 

  5. Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2013;24(1):23–57.

    CAS  Article  Google Scholar 

  6. Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, et al. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: Summary. CMAJ. 2010;182(17):1864–73.

    Article  Google Scholar 

  7. Ding LL, Wen F, Wang H, Wang DH, Liu Q, Mo YX, et al. Osteoporosis drugs for prevention of clinical fracture in white postmenopausal women: a network meta-analysis of survival data. Osteoporos Int. 2020;31(5):961–71.

    CAS  Article  Google Scholar 

  8. Cosman F, Crittenden DB, Adachi JD, Binkley N, Czerwinski E, Ferrari S, et al. Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med. 2016;375(16):1532–43.

    CAS  Article  Google Scholar 

  9. Cummings SR, Martin JS, McClung MR, Siris ES, Eastell R, Reid IR, et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009;361(8):756–65.

    CAS  Article  Google Scholar 

  10. Hansen L, Petersen KD, Eriksen SA, Gerstoft F, Vestergaard P. Subjects with osteoporosis to remain at high risk for fracture despite benefit of prior bisphosphonate treatment—a Danish case-control study. Osteoporos Int. 2017;28(1):321–8.

    CAS  Article  Google Scholar 

  11. Leslie WD, Majumdar SR, Morin SN, Lix LM. Why does rate of bone density loss not predict fracture risk? J Clin Endocrinol Metab. 2015;100(2):679–83.

    CAS  Article  Google Scholar 

  12. Cummings SR, Palermo L, Browner W, Marcus R, Wallace R, Pearson J, et al. Monitoring osteoporosis therapy with bone densitometry: Misleading changes and regression to the mean. J Am Med Assoc. 2000;283(10):1318–21.

    CAS  Article  Google Scholar 

  13. Leslie WD, Majumdar SR, Morin SN, Lix LM. Change in bone mineral density is an indicator of treatment-related antifracture effect in routine clinical practice: A registry-based cohort study. Ann Intern Med [Internet]. 2016;165(7):465–72. http://www.ncbi.nlm.nih.gov/pubmed/27428723. Cited 2020 May 12.

    Article  Google Scholar 

  14. Crandall CJ, Larson J, Wright NC, Laddu D, Stefanick ML, Kaunitz AM, et al. Serial Bone Density Measurement and Incident Fracture Risk Discrimination in Postmenopausal Women. JAMA Intern Med [Internet]. 2020;90024. Available from: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2768888.

  15. Qaseem A, Snow V, Shekelle P, Hopkins R, Forciea MA, Owens DK. Pharmacologic treatment of low bone density or osteoporosis to prevent fractures: A clinical practice guideline from the American College of Physicians. Ann Intern Med. 2008;149:404–15.

    Article  Google Scholar 

  16. Neumann I, Schünemann HJ. Guideline groups should make recommendations even if the evidence is considered insufficient. CMAJ. 2020;192(2):E23-24.

    Article  Google Scholar 

  17. Yeam CT, Chia S, Tan HCC, Kwan YH, Fong W, Seng JJB. A systematic review of factors affecting medication adherence among patients with osteoporosis. Osteoporos Int. 2018;29:2623–37.

    CAS  Article  Google Scholar 

  18. Cornelissen D, de Kunder S, Si L, Reginster JY, Evers S, Boonen A, et al. Interventions to improve adherence to anti-osteoporosis medications: an updated systematic review. Osteoporos Int. 2020;31:1645–69.

    CAS  Article  Google Scholar 

  19. Wadey VMR, Tang ET, Abelseth G, Dev P, Olshen RA, Walker D. Canadian multidisciplinary core curriculum for musculoskeletal health. J Rheumatol. 2007;34(3):567–80.

    PubMed  Google Scholar 

  20. Wadey VMR, Dev P, Buckley R, Walker D, Hedden D. Competencies for a Canadian orthopaedic surgery core curriculum. J Bone Joint Surg Br. 2009;91(12):1618–22.

    CAS  Article  Google Scholar 

  21. Giangregorio L, Fisher P, Papaioannou A, Adachi JD. Osteoporosis knowledge and information needs in healthcare professionals caring for patients with fragility fractures. Orthop Nurs. 2007;26(1):27.

    CAS  Article  Google Scholar 

  22. Jaglal SB, McIsaac WJ, Hawker G, Carroll J, Jaakkimainen L, Cadarette SM, et al. Information needs in the management of osteoporosis in family practice: An illustration of the failure of the current guideline implementation process. Osteoporos Int. 2003;14(8):672–6.

    Article  Google Scholar 

  23. Jaglal SB, Carroll J, Hawker G, McIsaac WJ, Jaakkimainen L, Cadarette SM, et al. How are family physicians managing osteoporosis?: Qualitative study of their experiences and educational needs. Can Fam Physician. 2003;49(4):462–8.

    PubMed  PubMed Central  Google Scholar 

  24. Jaglal SB, Hawker G, Bansod V, Salbach NM, Zwarenstein M, Carroll J, et al. A demonstration project of a multi-component educational intervention to improve integrated post-fracture osteoporosis care in five rural communities in Ontario, Canada. Osteoporos Int. 2009;20(2):265.

    CAS  Article  Google Scholar 

  25. Sasser AC, Rousculp MD, Birnbaum HG, Oster EF, Lufkin E, Mallet D. Economic burden of osteoporosis, breast cancer, and cardiovascular disease among postmenopausal women in an employed population. Womens Heal Issues. 2005;15(3):97–108.

    Article  Google Scholar 

Download references

Acknowledgements

Not applicable.

The Corresponding Author has the right to grant on behalf of all authors and does grant on behalf of all authors, a worldwide licence to the Publishers and its licensees in perpetuity, in all forms, formats and media (whether known now or created in the future), to i) publish, reproduce, distribute, display and store the Contribution, ii) translate the Contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or, abstracts of the Contribution, iii) create any other derivative work(s) based on the Contribution, iv) to exploit all subsidiary rights in the Contribution, v) the inclusion of electronic links from the Contribution to third party material where-ever it may be located; and, vi) licence any third party to do any or all of the above."

Funding

No funding required for this project.

Author information

Authors and Affiliations

Authors

Contributions

Gregory Kline conceived the project, secured the ethics approval, conducted the data abstraction and produced the first draft of the article. Christopher Symonds and Emma Billington assisted with data interpretation and critical review of the draft manuscript. The author(s) read and approved the final manuscript.

Corresponding author

Correspondence to Gregory A. Kline.

Ethics declarations

Ethics approval and consent to participate

This study was approved by and in accordance with the guidelines of ARECCI (A pRoject Ethics Community Consensus Initiative) Quality Improvement Ethics Board of Alberta Innovates (approved April 1, 2020). Informed consent was waived on account of the project using existing information permitted under the scope of the Health Information Act (HIA).

Consent for publication

Not applicable.

Competing interests

Gregory Kline declares that he has no conflicts of interest.

Christopher Symonds declares that he has no conflicts of interest.

Emma Billington declares that she has no conflicts of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Table 1.

Basic demographics of patients referred to the Osteoporosis clinic.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kline, G.A., Symonds, C.J. & Billington, E.O. A retrospective review of the community medicine needs from osteoporosis services in Canada. BMC Endocr Disord 22, 78 (2022). https://doi.org/10.1186/s12902-022-01000-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12902-022-01000-y

Keywords

  • Osteoporosis
  • Metabolic bone disorders
  • Fractures
  • Bisphosphonates
  • Medical education
  • Knowledge translation
  • Osteoporosis guidelines